"HLA-G Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.
| Descriptor ID |
D059951
|
| MeSH Number(s) |
D12.776.395.550.489.700 D12.776.543.550.439.700 D23.050.301.500.100.700 D23.050.301.500.450.700 D23.050.705.552.100.700 D23.050.705.552.450.700
|
| Concept/Terms |
HLA-G Antigens- HLA-G Antigens
- Antigens, HLA-G
- HLA G Antigens
- HLA-G Antigen
- Antigen, HLA-G
- HLA G Antigen
- HLA G
- HLA-G
HLA-G7 Isoform- HLA-G7 Isoform
- HLA G7 Isoform
- Isoform, HLA-G7
- HLA-G7
- HLA-G7 Antigen
- Antigen, HLA-G7
- HLA G7 Antigen
|
Below are MeSH descriptors whose meaning is more general than "HLA-G Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA-G Antigens".
This graph shows the total number of publications written about "HLA-G Antigens" by people in this website by year, and whether "HLA-G Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA-G Antigens" by people in Profiles.
-
EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma. Cancer Biomark. 2024; 39(4):289-298.
-
Comparison of Four Protocols for In Vitro Differentiation of Human Embryonic Stem Cells into Trophoblast Lineages by BMP4 and Dual Inhibition of Activin/Nodal and FGF2 Signaling. Reprod Sci. 2024 01; 31(1):173-189.
-
Systematic Evaluation of HLA-G 3'Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome. Front Immunol. 2021; 12:817132.
-
HLA-G 3'UTR haplotype frequencies in highland and lowland South Native American populations. Hum Immunol. 2022 Jan; 83(1):27-38.
-
HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant. Hum Immunol. 2020 Apr; 81(4):141-146.
-
HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer. Sci Rep. 2019 04 01; 9(1):5407.
-
Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation. Int J Mol Sci. 2017 Nov 05; 18(11).
-
Gene conversion of the major histocompatibility complex class I Caja-G in common marmosets (Callithrix jacchus). Immunology. 2016 Nov; 149(3):343-352.
-
A tug-of-war between tolerance and rejection - New evidence for 3'UTR HLA-G haplotypes influence in recurrent pregnancy loss. Hum Immunol. 2016 Oct; 77(10):892-897.
-
HLA-G1, but Not HLA-G3, Suppresses Human Monocyte/Macrophage-mediated Swine Endothelial Cell Lysis. Transplant Proc. 2016 May; 48(4):1285-7.